NIA-AA Symposium: Enabling Precision Medicine for Alzheimer’s Disease Through Open Science

Advance the conversation around Alzheimer’s precision medicine and open science

Join us for this year’s NIA-AA Symposium: Enabling Precision Medicine for Alzheimer’s Disease Through Open Science, a no-cost virtual conference on dementia research and precision medicine, supported by the Alzheimer’s Association and the National Institute on Aging (NIA).

This virtual symposium will feature an array of NIA-supported translational dementia research programs that employ precision medicine principles and open-science practices to:

1. Understand the complex and heterogeneous etiology of Alzheimer’s.
2. Identify new disease-relevant targets and biomarkers.
3. Develop the next generation animal models for late onset AD.
4. Advance novel targets into drug discovery by developing target enabling research tools.

View the 2021 agenda.

Conference program

The conference program will feature scientific advances on precision medicine and translational research for dementia and translational infrastructure resources developed by the:

• Accelerating Medicines Partnership® Alzheimer’s Disease (AMP AD®).
• Alzheimer’s Gut Microbiome Project (AGMP).
• MODEL-AD Consortium.
• TREAT-AD Centers.
• Alzheimer’s Biomarkers Consortium — Down Syndrome (ABC-DS).
• And others.

View the recorded 2021 NIA-AA Symposium now — at no cost.

Audience

Academic, biotech and pharmaceutical industry researchers with interests in target and biomarker discovery, personalized medicine, preclinical and clinical drug development; computational biologists; data scientists; and open science advocates.

Contact

General questions: PrecisionMedicine@alz.org
Media questions: media@alz.org